Manuel Alba sold $8.5M of ALAB
director at Astera Labs, Inc.. 93,991 shares at an average of $90.34, traded Jul 2, 2025, filed Jul 7, 2025.
Score components
- +15RoleDirector
- +25Trade size$8.5M at market
- +5Share of holdings soldSold 22% of holdings
- +15Cluster4 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001736297-25-000076, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jul 2, 2025 | SOpen-market sale Common Stockindirect: By Casa Alameda 2007, LLC10b5-1 | -4,278 | $88.71 | $380k | 428,576 | Jul 7, 2025 |
| Jul 2, 2025 | SOpen-market sale Common Stockindirect: By Casa Alameda 2007, LLC10b5-1 | -2,819 | $89.58 | $253k | 425,757 | Jul 7, 2025 |
| Jul 2, 2025 | SOpen-market sale Common Stockindirect: By Casa Alameda 2007, LLC10b5-1 | -2,448 | $90.62 | $222k | 423,309 | Jul 7, 2025 |
| Jul 2, 2025 | SOpen-market sale Common Stockindirect: By Casa Alameda 2007, LLC10b5-1 | -1,654 | $91.62 | $152k | 421,655 | Jul 7, 2025 |
| Jul 2, 2025 | SOpen-market sale Common Stockindirect: By Casa Alameda 2007, LLC10b5-1 | -801 | $92.37 | $74k | 420,854 | Jul 7, 2025 |
| Jul 2, 2025 | SOpen-market sale Common Stockindirect: By Alba Trust10b5-1 | -18,179 | $88.71 | $1.6M | 1,949,578 | Jul 7, 2025 |
| Jul 2, 2025 | SOpen-market sale Common Stockindirect: By Alba Trust10b5-1 | -11,980 | $89.58 | $1.1M | 1,937,598 | Jul 7, 2025 |
| Jul 2, 2025 | SOpen-market sale Common Stockindirect: By Alba Trust10b5-1 | -10,404 | $90.62 | $943k | 1,927,194 | Jul 7, 2025 |
| Jul 2, 2025 | SOpen-market sale Common Stockindirect: By Alba Trust10b5-1 | -7,030 | $91.62 | $644k | 1,920,164 | Jul 7, 2025 |
| Jul 2, 2025 | SOpen-market sale Common Stockindirect: By Alba Trust10b5-1 | -3,407 | $92.37 | $315k | 1,916,757 | Jul 7, 2025 |
| Jul 3, 2025 | SOpen-market sale Common Stockindirect: By Casa Alameda 2007, LLC10b5-1 | -195 | $89.74 | $17k | 420,659 | Jul 7, 2025 |
| Jul 3, 2025 | SOpen-market sale Common Stockindirect: By Casa Alameda 2007, LLC10b5-1 | -837 | $90.59 | $76k | 419,822 | Jul 7, 2025 |
| Jul 3, 2025 | SOpen-market sale Common Stockindirect: By Casa Alameda 2007, LLC10b5-1 | -543 | $91.49 | $50k | 419,279 | Jul 7, 2025 |
| Jul 3, 2025 | SOpen-market sale Common Stockindirect: By Casa Alameda 2007, LLC10b5-1 | -413 | $92.38 | $38k | 418,866 | Jul 7, 2025 |
| Jul 3, 2025 | SOpen-market sale Common Stockindirect: By Casa Alameda 2007, LLC10b5-1 | -3 | $93.14 | $279 | 418,863 | Jul 7, 2025 |
| Jul 3, 2025 | SOpen-market sale Common Stockindirect: By Alba Trust10b5-1 | -2,835 | $89.74 | $254k | 1,913,922 | Jul 7, 2025 |
| Jul 3, 2025 | SOpen-market sale Common Stockindirect: By Alba Trust10b5-1 | -12,185 | $90.58 | $1.1M | 1,901,737 | Jul 7, 2025 |
| Jul 3, 2025 | SOpen-market sale Common Stockindirect: By Alba Trust10b5-1 | -7,914 | $91.49 | $724k | 1,893,823 | Jul 7, 2025 |
| Jul 3, 2025 | SOpen-market sale Common Stockindirect: By Alba Trust10b5-1 | -6,018 | $92.38 | $556k | 1,887,805 | Jul 7, 2025 |
| Jul 3, 2025 | SOpen-market sale Common Stockindirect: By Alba Trust10b5-1 | -48 | $93.14 | $4,471 | 1,887,757 | Jul 7, 2025 |
Related signals
Other insiders at Astera Labs, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 25Weak | Astera Labs, Inc. | Stefan A Dyckerhoff director | $4.7M 12,499 shares | -25% | |
| 33Weak | Astera Labs, Inc. | Manuel Alba director | $51M 183,000 shares | -14% | |
| 33Weak | Astera Labs, Inc. | Stefan A Dyckerhoff director | $3.4M 12,499 shares | -23% | |
| 20Weak | Astera Labs, Inc. | Manuel Alba director | $25M 150,000 shares | -9% | |
| 20Weak | Astera Labs, Inc. | Manuel Alba director | $5.5M 33,000 shares | -9% | |
| 35Weak | Astera Labs, Inc. | Manuel Alba director | $32M 183,000 shares | -10% | |
| 35Weak | Astera Labs, Inc. | Philip Mazzara General Counsel and Secretary | $1.9M 10,000 shares | -6% | |
| 40Moderate | Astera Labs, Inc. | Jack R Lazar director | $4.0M 22,500 shares | -19% | |
| 62Notable | Astera Labs, Inc. | Michael Truett Tate Chief Financial Officer | $3.5M 18,861 shares | -7% | |
| 65Notable | Astera Labs, Inc. | Jitendra Mohan Chief Executive Officer | $17M 91,441 shares | -4% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.